

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil mediated immunity (GO:0002446) | 6.90212465 |
| 2 | negative regulation of phagocytosis (GO:0050765) | 5.50801760 |
| 3 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.49905493 |
| 4 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.49905493 |
| 5 | myeloid leukocyte mediated immunity (GO:0002444) | 5.27932398 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.02860015 |
| 7 | response to fungus (GO:0009620) | 4.93082894 |
| 8 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.90085257 |
| 9 | mature B cell differentiation involved in immune response (GO:0002313) | 4.79948869 |
| 10 | respiratory burst (GO:0045730) | 4.78434112 |
| 11 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.62779341 |
| 12 | regulation of growth of symbiont in host (GO:0044126) | 4.62779341 |
| 13 | negative regulation of growth of symbiont in host (GO:0044130) | 4.62779341 |
| 14 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.62779341 |
| 15 | leukocyte mediated cytotoxicity (GO:0001909) | 4.58037713 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.55659122 |
| 17 | mannose metabolic process (GO:0006013) | 4.48119909 |
| 18 | defense response to fungus (GO:0050832) | 4.46890713 |
| 19 | definitive hemopoiesis (GO:0060216) | 4.46203400 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.26238541 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.26238541 |
| 22 | positive regulation of granulocyte differentiation (GO:0030854) | 4.24662554 |
| 23 | cellular extravasation (GO:0045123) | 4.19658792 |
| 24 | leukocyte aggregation (GO:0070486) | 4.13102858 |
| 25 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.12010049 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.10126940 |
| 27 | killing of cells of other organism (GO:0031640) | 4.02534560 |
| 28 | disruption of cells of other organism (GO:0044364) | 4.02534560 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00874713 |
| 30 | cellular response to zinc ion (GO:0071294) | 3.97780408 |
| 31 | mature B cell differentiation (GO:0002335) | 3.83341194 |
| 32 | response to peptidoglycan (GO:0032494) | 3.79747625 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.79312579 |
| 34 | neutrophil activation (GO:0042119) | 3.72286571 |
| 35 | reactive oxygen species biosynthetic process (GO:1903409) | 3.69635398 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.63168776 |
| 37 | positive regulation of B cell differentiation (GO:0045579) | 3.62028428 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.58024809 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.58024809 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.58024809 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.58024809 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.58024809 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.58024809 |
| 44 | Peyers patch development (GO:0048541) | 3.56672671 |
| 45 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.56672671 |
| 46 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.55522362 |
| 47 | negative regulation of cell killing (GO:0031342) | 3.55522362 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.49567637 |
| 49 | positive regulation of mast cell degranulation (GO:0043306) | 3.49391542 |
| 50 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.49391542 |
| 51 | pinocytosis (GO:0006907) | 3.44997809 |
| 52 | regulation of hypersensitivity (GO:0002883) | 3.42111320 |
| 53 | mast cell activation (GO:0045576) | 3.41382826 |
| 54 | granulocyte activation (GO:0036230) | 3.40921257 |
| 55 | microglial cell activation (GO:0001774) | 3.40325945 |
| 56 | regulation of granulocyte differentiation (GO:0030852) | 3.34516586 |
| 57 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.33276954 |
| 58 | leukotriene metabolic process (GO:0006691) | 3.29321307 |
| 59 | actin nucleation (GO:0045010) | 3.27644652 |
| 60 | negative regulation of granulocyte differentiation (GO:0030853) | 3.24759168 |
| 61 | T cell migration (GO:0072678) | 3.23450576 |
| 62 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.23355379 |
| 63 | negative regulation of interleukin-8 production (GO:0032717) | 3.22110574 |
| 64 | leukocyte degranulation (GO:0043299) | 3.19478366 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 3.15646367 |
| 66 | response to muramyl dipeptide (GO:0032495) | 3.14561222 |
| 67 | cell killing (GO:0001906) | 3.14135068 |
| 68 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.10714176 |
| 69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.09383302 |
| 70 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05896744 |
| 71 | negative thymic T cell selection (GO:0045060) | 3.05653704 |
| 72 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05614295 |
| 73 | immunoglobulin mediated immune response (GO:0016064) | 3.05602999 |
| 74 | leukotriene biosynthetic process (GO:0019370) | 3.05585519 |
| 75 | negative regulation of interleukin-17 production (GO:0032700) | 3.05046597 |
| 76 | regulation of B cell differentiation (GO:0045577) | 3.03441550 |
| 77 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.00747373 |
| 78 | natural killer cell mediated immunity (GO:0002228) | 3.00747373 |
| 79 | pentose-phosphate shunt (GO:0006098) | 3.00356866 |
| 80 | regulation of mast cell activation (GO:0033003) | 2.98801381 |
| 81 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.97724703 |
| 82 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.97369183 |
| 83 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.96303486 |
| 84 | mast cell degranulation (GO:0043303) | 2.95113254 |
| 85 | mast cell activation involved in immune response (GO:0002279) | 2.95113254 |
| 86 | protein localization to kinetochore (GO:0034501) | 2.94073999 |
| 87 | phospholipid scrambling (GO:0017121) | 2.93990542 |
| 88 | positive T cell selection (GO:0043368) | 2.93841280 |
| 89 | macrophage activation (GO:0042116) | 2.93554567 |
| 90 | cellular response to ethanol (GO:0071361) | 2.93070489 |
| 91 | DNA unwinding involved in DNA replication (GO:0006268) | 2.91644423 |
| 92 | negative T cell selection (GO:0043383) | 2.90445081 |
| 93 | negative regulation of T cell mediated immunity (GO:0002710) | 2.89202545 |
| 94 | megakaryocyte development (GO:0035855) | 2.88344134 |
| 95 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.88297200 |
| 96 | natural killer cell activation involved in immune response (GO:0002323) | 2.87536069 |
| 97 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86978453 |
| 98 | regulation of regulated secretory pathway (GO:1903305) | 2.86761970 |
| 99 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.86554267 |
| 100 | detection of other organism (GO:0098543) | 2.86181861 |
| 101 | superoxide anion generation (GO:0042554) | 2.84088338 |
| 102 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.82449753 |
| 103 | sequestering of metal ion (GO:0051238) | 2.81803188 |
| 104 | angiogenesis involved in wound healing (GO:0060055) | 2.80944932 |
| 105 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.80140190 |
| 106 | ribosomal small subunit assembly (GO:0000028) | 2.79967652 |
| 107 | cellular response to exogenous dsRNA (GO:0071360) | 2.79894141 |
| 108 | DNA strand elongation (GO:0022616) | 2.79038378 |
| 109 | interkinetic nuclear migration (GO:0022027) | 2.78732111 |
| 110 | cell wall macromolecule catabolic process (GO:0016998) | 2.78447850 |
| 111 | negative regulation of interleukin-6 production (GO:0032715) | 2.77677162 |
| 112 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.76697550 |
| 113 | interferon-gamma production (GO:0032609) | 2.76145903 |
| 114 | positive regulation of mast cell activation (GO:0033005) | 2.74827267 |
| 115 | B cell receptor signaling pathway (GO:0050853) | 2.73702273 |
| 116 | NADPH regeneration (GO:0006740) | 2.73610272 |
| 117 | regulation of mast cell degranulation (GO:0043304) | 2.71413229 |
| 118 | leukocyte cell-cell adhesion (GO:0007159) | 2.71359667 |
| 119 | regulation of erythrocyte differentiation (GO:0045646) | 2.70006091 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.69574596 |
| 121 | detection of molecule of bacterial origin (GO:0032490) | 2.69554916 |
| 122 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.67864708 |
| 123 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.67808802 |
| 124 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.66375000 |
| 125 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.66375000 |
| 126 | response to protozoan (GO:0001562) | 2.66076342 |
| 127 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.65654463 |
| 128 | telomere maintenance via recombination (GO:0000722) | 2.64809411 |
| 129 | fucose catabolic process (GO:0019317) | 2.64549744 |
| 130 | L-fucose metabolic process (GO:0042354) | 2.64549744 |
| 131 | L-fucose catabolic process (GO:0042355) | 2.64549744 |
| 132 | positive regulation of leukocyte degranulation (GO:0043302) | 2.64192128 |
| 133 | regulation of germinal center formation (GO:0002634) | 2.62700395 |
| 134 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.61547682 |
| 135 | hepatocyte apoptotic process (GO:0097284) | 2.60427127 |
| 136 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.59271554 |
| 137 | regulation of leukocyte degranulation (GO:0043300) | 2.58527172 |
| 138 | protein localization to chromosome, centromeric region (GO:0071459) | 2.57705477 |
| 139 | positive thymic T cell selection (GO:0045059) | 2.55788856 |
| 140 | macrophage differentiation (GO:0030225) | 2.54977015 |
| 141 | regulation of gamma-delta T cell activation (GO:0046643) | 2.54599832 |
| 142 | response to host immune response (GO:0052572) | 2.54369032 |
| 143 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.54369032 |
| 144 | negative regulation of interleukin-12 production (GO:0032695) | 2.53564298 |
| 145 | defense response to protozoan (GO:0042832) | 2.53331809 |
| 146 | leukocyte mediated immunity (GO:0002443) | 2.53267563 |
| 147 | macrophage activation involved in immune response (GO:0002281) | 2.50544940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.23023262 |
| 2 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.69151528 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.68858828 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.61702293 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.46595274 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.29203619 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.23500244 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.14857916 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.00696185 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.82300338 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.78727760 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.78555517 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72403521 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59487973 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.57017649 |
| 16 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.52545493 |
| 17 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.51638942 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50574915 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.49364219 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.46634040 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46626186 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.30167560 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.30054944 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23540469 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.15775948 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.13201594 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.13141650 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.12783175 |
| 29 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08752350 |
| 30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.07196705 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.06975541 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.05256392 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00069932 |
| 34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.99871170 |
| 35 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.96418621 |
| 36 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94179735 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85529894 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.81494297 |
| 39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79858401 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.74860546 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.71687505 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71255901 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68749283 |
| 44 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65964055 |
| 45 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.61485858 |
| 46 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.60781369 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60714070 |
| 48 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59026363 |
| 49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.57736299 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57063184 |
| 51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.52687248 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52105510 |
| 53 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.51623949 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50515430 |
| 55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49850795 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48893485 |
| 57 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.46027176 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45631697 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.43835979 |
| 60 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42278489 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42018477 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36155650 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35439931 |
| 64 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.35243109 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34793386 |
| 66 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33906286 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33264937 |
| 68 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.31935339 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31585902 |
| 70 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.30615375 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25982714 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23611681 |
| 73 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.23369958 |
| 74 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.23219415 |
| 75 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22918785 |
| 76 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22033521 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21266342 |
| 78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20993505 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17261869 |
| 80 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.15002696 |
| 81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14919046 |
| 82 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.12550450 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11939934 |
| 84 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10598650 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09686907 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09007959 |
| 87 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.08905502 |
| 88 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.07594215 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 1.06611823 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05610737 |
| 91 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.05144563 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05092450 |
| 93 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04659786 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04635301 |
| 95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03805177 |
| 96 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03764978 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00853884 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00683493 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00079915 |
| 100 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.98880295 |
| 101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98736844 |
| 102 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97687777 |
| 103 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95714733 |
| 104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94932789 |
| 105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94352669 |
| 106 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93840863 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92980128 |
| 108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92311332 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91064790 |
| 110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90822023 |
| 111 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.88669285 |
| 112 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.87462536 |
| 113 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87242686 |
| 114 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87223379 |
| 115 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.87079775 |
| 116 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.84668843 |
| 117 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.84610688 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84550129 |
| 119 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.84232502 |
| 120 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83674185 |
| 121 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.83319099 |
| 122 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79100150 |
| 123 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79048864 |
| 124 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78151260 |
| 125 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76080396 |
| 126 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71635458 |
| 127 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.71250200 |
| 128 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.68051537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.52694817 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.38746730 |
| 3 | MP0003436_decreased_susceptibility_to | 3.19474126 |
| 4 | MP0002419_abnormal_innate_immunity | 2.98778130 |
| 5 | MP0003303_peritoneal_inflammation | 2.98568522 |
| 6 | MP0009785_altered_susceptibility_to | 2.84672568 |
| 7 | MP0000569_abnormal_digit_pigmentation | 2.71931367 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.67554806 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.66567875 |
| 10 | MP0005025_abnormal_response_to | 2.65229244 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.59073331 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.52421375 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.38825372 |
| 14 | MP0008057_abnormal_DNA_replication | 2.36815488 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.35743685 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.33924503 |
| 17 | MP0001819_abnormal_immune_cell | 2.32412540 |
| 18 | MP0005671_abnormal_response_to | 2.32012290 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.31365305 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.27665138 |
| 21 | MP0003828_pulmonary_edema | 2.23372526 |
| 22 | MP0001800_abnormal_humoral_immune | 2.22626433 |
| 23 | MP0003693_abnormal_embryo_hatching | 2.18282888 |
| 24 | MP0002723_abnormal_immune_serum | 2.15899132 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 2.14229300 |
| 26 | MP0002398_abnormal_bone_marrow | 2.13574767 |
| 27 | MP0000685_abnormal_immune_system | 2.12178042 |
| 28 | MP0003763_abnormal_thymus_physiology | 2.06467089 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 2.06011491 |
| 30 | MP0001545_abnormal_hematopoietic_system | 2.06011491 |
| 31 | MP0010094_abnormal_chromosome_stability | 2.04743163 |
| 32 | MP0010307_abnormal_tumor_latency | 1.98226682 |
| 33 | MP0002405_respiratory_system_inflammati | 1.96406937 |
| 34 | MP0002006_tumorigenesis | 1.94871275 |
| 35 | MP0000716_abnormal_immune_system | 1.93610845 |
| 36 | MP0003111_abnormal_nucleus_morphology | 1.92124032 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.89791921 |
| 38 | MP0001790_abnormal_immune_system | 1.88667042 |
| 39 | MP0005387_immune_system_phenotype | 1.88667042 |
| 40 | MP0009278_abnormal_bone_marrow | 1.81441655 |
| 41 | MP0003724_increased_susceptibility_to | 1.78982895 |
| 42 | MP0000858_altered_metastatic_potential | 1.77315491 |
| 43 | MP0000015_abnormal_ear_pigmentation | 1.76421827 |
| 44 | MP0002722_abnormal_immune_system | 1.74592231 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.74590299 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.72892597 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.71049986 |
| 48 | MP0002429_abnormal_blood_cell | 1.70599853 |
| 49 | MP0000490_abnormal_crypts_of | 1.69911116 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.66752383 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.66588783 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.65157591 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.62828384 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.52408073 |
| 55 | MP0003077_abnormal_cell_cycle | 1.51387252 |
| 56 | MP0001853_heart_inflammation | 1.50151538 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.48080945 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.44726285 |
| 59 | MP0001873_stomach_inflammation | 1.42301061 |
| 60 | MP0006082_CNS_inflammation | 1.42006052 |
| 61 | MP0000343_altered_response_to | 1.33926219 |
| 62 | MP0002095_abnormal_skin_pigmentation | 1.29234342 |
| 63 | MP0003448_altered_tumor_morphology | 1.28880995 |
| 64 | MP0006054_spinal_hemorrhage | 1.27881044 |
| 65 | MP0008058_abnormal_DNA_repair | 1.25515045 |
| 66 | MP0001851_eye_inflammation | 1.24550185 |
| 67 | MP0002019_abnormal_tumor_incidence | 1.22374708 |
| 68 | MP0008469_abnormal_protein_level | 1.19908848 |
| 69 | MP0004947_skin_inflammation | 1.13399217 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 1.12480224 |
| 71 | MP0003866_abnormal_defecation | 1.07968720 |
| 72 | MP0000371_diluted_coat_color | 1.04633493 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.03683594 |
| 74 | MP0005076_abnormal_cell_differentiation | 1.02812336 |
| 75 | MP0003566_abnormal_cell_adhesion | 1.01873627 |
| 76 | MP0004957_abnormal_blastocyst_morpholog | 0.98097741 |
| 77 | MP0004883_abnormal_blood_vessel | 0.97998066 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.97715136 |
| 79 | MP0008007_abnormal_cellular_replicative | 0.93486480 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 0.93380777 |
| 81 | MP0004130_abnormal_muscle_cell | 0.93267750 |
| 82 | MP0005164_abnormal_response_to | 0.92569379 |
| 83 | MP0005666_abnormal_adipose_tissue | 0.92453867 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 0.91673991 |
| 85 | MP0000313_abnormal_cell_death | 0.90932459 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.89073263 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88437511 |
| 88 | MP0005310_abnormal_salivary_gland | 0.85849349 |
| 89 | MP0009763_increased_sensitivity_to | 0.83684970 |
| 90 | MP0005390_skeleton_phenotype | 0.83501212 |
| 91 | MP0009764_decreased_sensitivity_to | 0.82280520 |
| 92 | MP0005166_decreased_susceptibility_to | 0.80569514 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.79494699 |
| 94 | MP0005409_darkened_coat_color | 0.76411942 |
| 95 | MP0001663_abnormal_digestive_system | 0.76231154 |
| 96 | MP0003075_altered_response_to | 0.73707701 |
| 97 | MP0002933_joint_inflammation | 0.73590006 |
| 98 | MP0000681_abnormal_thyroid_gland | 0.72300093 |
| 99 | MP0000350_abnormal_cell_proliferation | 0.68854614 |
| 100 | MP0008877_abnormal_DNA_methylation | 0.68654860 |
| 101 | MP0004147_increased_porphyrin_level | 0.67925500 |
| 102 | MP0005621_abnormal_cell_physiology | 0.67706129 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.67617407 |
| 104 | MP0003795_abnormal_bone_structure | 0.66857000 |
| 105 | MP0009115_abnormal_fat_cell | 0.66742078 |
| 106 | MP0003191_abnormal_cellular_cholesterol | 0.66023024 |
| 107 | MP0008873_increased_physiological_sensi | 0.65516220 |
| 108 | MP0000604_amyloidosis | 0.63781148 |
| 109 | MP0004510_myositis | 0.62010937 |
| 110 | MP0004484_altered_response_of | 0.61931636 |
| 111 | MP0002009_preneoplasia | 0.61680573 |
| 112 | MP0005165_increased_susceptibility_to | 0.60528292 |
| 113 | MP0003806_abnormal_nucleotide_metabolis | 0.60308168 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.59810380 |
| 115 | MP0000249_abnormal_blood_vessel | 0.59367473 |
| 116 | MP0009840_abnormal_foam_cell | 0.58735379 |
| 117 | MP0005384_cellular_phenotype | 0.58528448 |
| 118 | MP0005334_abnormal_fat_pad | 0.58094439 |
| 119 | MP0001915_intracranial_hemorrhage | 0.57572000 |
| 120 | MP0002075_abnormal_coat/hair_pigmentati | 0.57405895 |
| 121 | MP0005647_abnormal_sex_gland | 0.57374291 |
| 122 | MP0004264_abnormal_extraembryonic_tissu | 0.55640768 |
| 123 | MP0005319_abnormal_enzyme/_coenzyme | 0.54371847 |
| 124 | MP0005535_abnormal_body_temperature | 0.54073067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.36691615 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.05084438 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.88057753 |
| 4 | Thrombocytosis (HP:0001894) | 5.33393039 |
| 5 | Obstructive lung disease (HP:0006536) | 4.77280375 |
| 6 | Chronic obstructive pulmonary disease (HP:0006510) | 4.77280375 |
| 7 | Myositis (HP:0100614) | 4.47741010 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.30750259 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.26336687 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.03276144 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.03276144 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.03276144 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.98067839 |
| 14 | Periodontitis (HP:0000704) | 3.82284724 |
| 15 | Recurrent skin infections (HP:0001581) | 3.77770478 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.69761888 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.64946646 |
| 18 | Abnormality of the prostate (HP:0008775) | 3.57100960 |
| 19 | Meningitis (HP:0001287) | 3.53597688 |
| 20 | Recurrent viral infections (HP:0004429) | 3.42617676 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.35164365 |
| 22 | Gingivitis (HP:0000230) | 3.28684674 |
| 23 | Orchitis (HP:0100796) | 3.24708358 |
| 24 | IgM deficiency (HP:0002850) | 3.22307811 |
| 25 | Eosinophilia (HP:0001880) | 3.20807442 |
| 26 | Autoimmune hemolytic anemia (HP:0001890) | 3.16620834 |
| 27 | Chest pain (HP:0100749) | 3.14300754 |
| 28 | Papilledema (HP:0001085) | 3.13864342 |
| 29 | Chronic otitis media (HP:0000389) | 3.12076266 |
| 30 | Optic neuritis (HP:0100653) | 3.05787417 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 3.05787417 |
| 32 | Agammaglobulinemia (HP:0004432) | 3.05163671 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 3.03555028 |
| 34 | Colitis (HP:0002583) | 3.00916199 |
| 35 | Granulocytopenia (HP:0001913) | 2.97424476 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.92755772 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.92755772 |
| 38 | Vasculitis (HP:0002633) | 2.89208149 |
| 39 | Hemoptysis (HP:0002105) | 2.81960747 |
| 40 | Leukocytosis (HP:0001974) | 2.80793736 |
| 41 | Cellulitis (HP:0100658) | 2.77111678 |
| 42 | Stomatitis (HP:0010280) | 2.76325790 |
| 43 | Petechiae (HP:0000967) | 2.75183190 |
| 44 | Chromsome breakage (HP:0040012) | 2.73665463 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.67862167 |
| 46 | B lymphocytopenia (HP:0010976) | 2.67573197 |
| 47 | Abnormality of B cell number (HP:0010975) | 2.67573197 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.64498584 |
| 49 | Agnosia (HP:0010524) | 2.60860723 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.60065872 |
| 51 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.58458773 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.58116877 |
| 53 | Abnormality of eosinophils (HP:0001879) | 2.57787602 |
| 54 | Osteomyelitis (HP:0002754) | 2.56708647 |
| 55 | Epistaxis (HP:0000421) | 2.56016852 |
| 56 | Impaired platelet aggregation (HP:0003540) | 2.53144297 |
| 57 | Abnormal platelet function (HP:0011869) | 2.53144297 |
| 58 | Spondylolisthesis (HP:0003302) | 2.49277813 |
| 59 | Arterial thrombosis (HP:0004420) | 2.47896152 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 2.45870774 |
| 61 | Abnormality of T cells (HP:0002843) | 2.43872137 |
| 62 | Poikiloderma (HP:0001029) | 2.40947328 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40498747 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40498747 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40498747 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.38578937 |
| 67 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.37440239 |
| 68 | Urticaria (HP:0001025) | 2.37133764 |
| 69 | Prolonged bleeding time (HP:0003010) | 2.36634695 |
| 70 | Mucopolysacchariduria (HP:0008155) | 2.36528720 |
| 71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.36528720 |
| 72 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.34779945 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.34613224 |
| 74 | Amyloidosis (HP:0011034) | 2.32578421 |
| 75 | Loss of speech (HP:0002371) | 2.31825590 |
| 76 | Prostate neoplasm (HP:0100787) | 2.30626546 |
| 77 | Increased IgE level (HP:0003212) | 2.30486211 |
| 78 | Acute myeloid leukemia (HP:0004808) | 2.28791494 |
| 79 | Keratoconjunctivitis (HP:0001096) | 2.28267805 |
| 80 | Widely spaced teeth (HP:0000687) | 2.26394827 |
| 81 | Abnormality of the fingertips (HP:0001211) | 2.26084568 |
| 82 | Pulmonary embolism (HP:0002204) | 2.25731511 |
| 83 | Cutaneous melanoma (HP:0012056) | 2.25082054 |
| 84 | Gangrene (HP:0100758) | 2.22244226 |
| 85 | Encephalitis (HP:0002383) | 2.22235602 |
| 86 | Myelodysplasia (HP:0002863) | 2.22230100 |
| 87 | Pustule (HP:0200039) | 2.20014125 |
| 88 | Reticulocytopenia (HP:0001896) | 2.18499854 |
| 89 | Skin ulcer (HP:0200042) | 2.18358431 |
| 90 | T lymphocytopenia (HP:0005403) | 2.17198755 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 2.16547237 |
| 92 | Amaurosis fugax (HP:0100576) | 2.16155986 |
| 93 | Interstitial pulmonary disease (HP:0006530) | 2.15856127 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 2.15616298 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 2.15153253 |
| 96 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.14856480 |
| 97 | Pulmonary fibrosis (HP:0002206) | 2.13921425 |
| 98 | Severe combined immunodeficiency (HP:0004430) | 2.11320809 |
| 99 | Abnormality of the thoracic spine (HP:0100711) | 2.11028627 |
| 100 | Gingival bleeding (HP:0000225) | 2.10312753 |
| 101 | Abnormal platelet volume (HP:0011876) | 2.07648122 |
| 102 | Recurrent pneumonia (HP:0006532) | 2.07123811 |
| 103 | Abnormality of DNA repair (HP:0003254) | 2.06772594 |
| 104 | Viral hepatitis (HP:0006562) | 2.06349527 |
| 105 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.06077363 |
| 106 | Increased cerebral lipofuscin (HP:0011813) | 2.04790600 |
| 107 | Abnormality of T cell number (HP:0011839) | 2.04617746 |
| 108 | Thrombophlebitis (HP:0004418) | 2.03581515 |
| 109 | Sepsis (HP:0100806) | 2.03440904 |
| 110 | Gastrointestinal infarctions (HP:0005244) | 2.03301157 |
| 111 | Entropion (HP:0000621) | 2.03293891 |
| 112 | J-shaped sella turcica (HP:0002680) | 2.01469319 |
| 113 | Panhypogammaglobulinemia (HP:0003139) | 2.01004882 |
| 114 | Thoracic kyphosis (HP:0002942) | 2.00712402 |
| 115 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.00570594 |
| 116 | Acute lymphatic leukemia (HP:0006721) | 1.98940904 |
| 117 | Glomerulopathy (HP:0100820) | 1.98820362 |
| 118 | Recurrent bronchitis (HP:0002837) | 1.98432505 |
| 119 | Hypochromic microcytic anemia (HP:0004840) | 1.98081616 |
| 120 | Fatigue (HP:0012378) | 1.97348717 |
| 121 | Lymphoma (HP:0002665) | 1.96924453 |
| 122 | Autoimmune thrombocytopenia (HP:0001973) | 1.96821011 |
| 123 | Albinism (HP:0001022) | 1.96651981 |
| 124 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95732370 |
| 125 | Hepatosplenomegaly (HP:0001433) | 1.95407935 |
| 126 | Lymphopenia (HP:0001888) | 1.94274922 |
| 127 | Thyroiditis (HP:0100646) | 1.94183870 |
| 128 | Basal ganglia calcification (HP:0002135) | 1.92915004 |
| 129 | Disinhibition (HP:0000734) | 1.92002994 |
| 130 | Cheilitis (HP:0100825) | 1.90546441 |
| 131 | Joint hemorrhage (HP:0005261) | 1.90021311 |
| 132 | Neutropenia (HP:0001875) | 1.89797683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.16050511 |
| 2 | IRAK4 | 3.93584542 |
| 3 | TAOK3 | 3.54499967 |
| 4 | MAP4K1 | 3.13999840 |
| 5 | TEC | 2.46170012 |
| 6 | KIT | 2.40273588 |
| 7 | BLK | 2.34269902 |
| 8 | BTK | 2.28415307 |
| 9 | STK10 | 2.20257045 |
| 10 | TXK | 2.10200407 |
| 11 | EEF2K | 2.10158363 |
| 12 | MAP3K14 | 2.06462889 |
| 13 | TGFBR2 | 1.99257913 |
| 14 | BMPR2 | 1.97607355 |
| 15 | FES | 1.95054556 |
| 16 | ZAP70 | 1.92415801 |
| 17 | FLT3 | 1.84346098 |
| 18 | PRPF4B | 1.83216063 |
| 19 | CDC7 | 1.81129373 |
| 20 | PKN2 | 1.79348559 |
| 21 | RIPK4 | 1.76749357 |
| 22 | ITK | 1.71396429 |
| 23 | TYK2 | 1.69926160 |
| 24 | MAP2K3 | 1.61304769 |
| 25 | PIM2 | 1.56886961 |
| 26 | JAK3 | 1.55797964 |
| 27 | SYK | 1.54931601 |
| 28 | PIK3CG | 1.54453146 |
| 29 | CLK1 | 1.48856841 |
| 30 | GRK7 | 1.45521316 |
| 31 | TRPM7 | 1.40796911 |
| 32 | IRAK3 | 1.38474581 |
| 33 | GRK6 | 1.31734382 |
| 34 | BRSK2 | 1.30707776 |
| 35 | WEE1 | 1.28183337 |
| 36 | TBK1 | 1.27506884 |
| 37 | IKBKE | 1.26581699 |
| 38 | NEK2 | 1.21626431 |
| 39 | HCK | 1.19644191 |
| 40 | LRRK2 | 1.19516688 |
| 41 | ATR | 1.18220525 |
| 42 | TESK2 | 1.15519284 |
| 43 | MAP3K12 | 1.15242353 |
| 44 | EPHB1 | 1.15202087 |
| 45 | PIM1 | 1.15169675 |
| 46 | SRPK1 | 1.14755740 |
| 47 | CSF1R | 1.12087443 |
| 48 | CSK | 1.09748163 |
| 49 | ERN1 | 1.09309605 |
| 50 | LCK | 1.03562536 |
| 51 | STK4 | 1.02035352 |
| 52 | IRAK1 | 1.01329495 |
| 53 | JAK1 | 1.00326655 |
| 54 | MOS | 0.99238623 |
| 55 | EIF2AK2 | 0.98041054 |
| 56 | PLK4 | 0.97568546 |
| 57 | SIK2 | 0.97258698 |
| 58 | MAP3K8 | 0.96946078 |
| 59 | STK24 | 0.96718080 |
| 60 | LYN | 0.95690551 |
| 61 | PIK3CA | 0.95507992 |
| 62 | TESK1 | 0.92761478 |
| 63 | RPS6KA4 | 0.91996909 |
| 64 | MAP3K6 | 0.89762275 |
| 65 | NUAK1 | 0.89436046 |
| 66 | ACVR1B | 0.89069345 |
| 67 | MAP3K10 | 0.88791081 |
| 68 | STK16 | 0.88210136 |
| 69 | ERBB3 | 0.87567771 |
| 70 | RPS6KC1 | 0.86409138 |
| 71 | RPS6KL1 | 0.86409138 |
| 72 | RPS6KA6 | 0.85406694 |
| 73 | TTN | 0.83149196 |
| 74 | RPS6KB2 | 0.81323087 |
| 75 | CHUK | 0.79906244 |
| 76 | RPS6KA2 | 0.78855195 |
| 77 | CDK4 | 0.78347497 |
| 78 | MAP3K1 | 0.76373104 |
| 79 | SCYL2 | 0.74652743 |
| 80 | MAP3K5 | 0.73638360 |
| 81 | PAK4 | 0.73574253 |
| 82 | IKBKB | 0.73534995 |
| 83 | IRAK2 | 0.72945752 |
| 84 | BRD4 | 0.72369479 |
| 85 | ABL1 | 0.72173050 |
| 86 | MAPK4 | 0.71890901 |
| 87 | NEK9 | 0.71012006 |
| 88 | DAPK1 | 0.67103325 |
| 89 | MARK3 | 0.64987082 |
| 90 | EIF2AK3 | 0.63603067 |
| 91 | JAK2 | 0.63368202 |
| 92 | MAP3K13 | 0.63066262 |
| 93 | MAP2K2 | 0.61692058 |
| 94 | CDK7 | 0.61358518 |
| 95 | FRK | 0.59002943 |
| 96 | CDK12 | 0.58219702 |
| 97 | CDK6 | 0.56896053 |
| 98 | PDK1 | 0.56184899 |
| 99 | VRK1 | 0.54894293 |
| 100 | MKNK1 | 0.50896008 |
| 101 | MAP3K11 | 0.50187382 |
| 102 | PTK6 | 0.49997806 |
| 103 | ABL2 | 0.49613910 |
| 104 | AURKB | 0.49520107 |
| 105 | BUB1 | 0.48620480 |
| 106 | TNK2 | 0.47371336 |
| 107 | TSSK6 | 0.46311325 |
| 108 | MATK | 0.46166484 |
| 109 | PRKCQ | 0.45693483 |
| 110 | MAPK3 | 0.44781582 |
| 111 | FGFR3 | 0.44553372 |
| 112 | TLK1 | 0.44518787 |
| 113 | MAPK7 | 0.43772369 |
| 114 | NME2 | 0.42742302 |
| 115 | HIPK2 | 0.42662121 |
| 116 | ALK | 0.42087793 |
| 117 | TGFBR1 | 0.41890535 |
| 118 | PASK | 0.41116242 |
| 119 | PLK1 | 0.41041534 |
| 120 | MAPK15 | 0.40878704 |
| 121 | MAPKAPK2 | 0.40729772 |
| 122 | RIPK1 | 0.40534600 |
| 123 | PRKCD | 0.40355099 |
| 124 | TRIB3 | 0.39639546 |
| 125 | RET | 0.39014831 |
| 126 | BRSK1 | 0.38266785 |
| 127 | MAP2K6 | 0.37813736 |
| 128 | TAOK2 | 0.36528716 |
| 129 | MAPK12 | 0.35021456 |
| 130 | MKNK2 | 0.34587060 |
| 131 | MAPK11 | 0.34515609 |
| 132 | CAMK1D | 0.34188545 |
| 133 | EPHA3 | 0.30027272 |
| 134 | IGF1R | 0.29301177 |
| 135 | FYN | 0.29103569 |
| 136 | PDPK1 | 0.28905975 |
| 137 | PRKD2 | 0.28238906 |
| 138 | CDK3 | 0.27753513 |
| 139 | CAMKK2 | 0.26857151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.33745374 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.89844991 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.82118420 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.07213239 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.06459020 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05168984 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.02229906 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.01360507 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 1.96055751 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96048577 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.86282247 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.82796794 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80343745 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77578558 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77416064 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.75368173 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.71569443 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.70816892 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.70692084 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.67398857 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67037295 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.61581814 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60525021 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59789940 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59619868 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58080480 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54742974 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.50905246 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.50196038 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.49080939 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.44518218 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.41999868 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41969671 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.41570235 |
| 35 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.38753695 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37964286 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.37159347 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.35167105 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.31149764 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30496267 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.27450470 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26010350 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.25791893 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.19937016 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19214487 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.17178813 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15979659 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.12292443 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 1.11171508 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10576216 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09278924 |
| 52 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.07960065 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07474546 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05448601 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03110107 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02788547 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02410234 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99902988 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99568838 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 0.98946548 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96689300 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94372717 |
| 63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.92601193 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.92554494 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91696291 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.90684203 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.90344031 |
| 68 | Ribosome_Homo sapiens_hsa03010 | 0.90312011 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84511070 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84440810 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82915398 |
| 72 | RNA transport_Homo sapiens_hsa03013 | 0.82647883 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80695764 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80609011 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.79844893 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79713770 |
| 77 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.79161653 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78846714 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76971343 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76564291 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75009980 |
| 82 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.74789393 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.74573957 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74466109 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.72346104 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71263441 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.70202442 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70051153 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68547415 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65043222 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64733257 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63884059 |
| 93 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61564398 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60359063 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59993776 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59698301 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59032104 |
| 98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58796782 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57320472 |
| 100 | Protein export_Homo sapiens_hsa03060 | 0.57265076 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53692988 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50141426 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49400300 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48016150 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46216627 |
| 106 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45131688 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44945588 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.44283628 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43676049 |
| 110 | RNA polymerase_Homo sapiens_hsa03020 | 0.42035966 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41971728 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40992477 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38881028 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38505390 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.38202585 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38017003 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38015931 |
| 118 | Salivary secretion_Homo sapiens_hsa04970 | 0.37423938 |
| 119 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.36979872 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.35779401 |
| 121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34765790 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34678462 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34650525 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34547883 |
| 125 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33418893 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33280037 |
| 127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32651047 |
| 128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31781054 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30891380 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30050548 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28660998 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.24622726 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23412290 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21796201 |
| 135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.19311060 |

